Scientists delve deeper into how vaccines work against leishmaniasis

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.

Retinal Degeneration drugs in development, 2023

GlobalData tracks 76 drugs in development for Retinal Degeneration by 63 companies/universities/institutes. The top development phase for Retinal Degeneration is preclinical, with 40 drugs in

March 21, 2024

Spouting COVID Misinformation Tied to Use of Ivermectin, HCQ

Endorsing COVID-19 vaccine misinformation, lack of trust in physicians or scientists, and conspiracy-mindedness were linked to the use of non-evidence-based treatments for COVID-19, an internet-based

September 30, 2023

Updated: Sage reports Phase 2 failure in Huntington’s disease, ends drug’s development

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.